atx crypto club

coronavirus

#coronavirus

Anon Ymous

Tue Jun 22 21:26:24 2021
(*5e05c158*):: Potential Risks and Benefits of Gain-of-Function Research +public!
–2015–
— Potential Risks and Benefits of Gain-of-Function Research
— On October 17, 2014, spurred by incidents at U.S. government laboratories that raised serious biosafety concerns, the United States government launched a one-year deliberative process to address the continuing controversy surrounding so-called “gain-of-function” (GOF) research on respiratory pathogens with pandemic potential. The gain of function controversy began in late 2011 with the question of whether to publish the results of two experiments involving H5N1 avian influenza and continued to focus on certain research with highly pathogenic avian influenza over the next three years. The heart of the U.S. process is an evaluation of the potential risks and benefits of certain types of GOF experiments with influenza, SARS, and MERS viruses that would inform the development and adoption of a new U.S. Government policy governing the funding and conduct of GOF research.

(*5e05c158*):: (2000) Vaccines for the 21st Century +Public!
— Vaccines for the 21st Century
— Vaccines have made it possible to eradicate the scourge of smallpox, promise the same for polio, and have profoundly reduced the threat posed by other diseases such as whooping cough, measles, and meningitis.

(*5e05c158*):: +public! The 2009 H1N1 Influenza Vaccination Campaign (2010)
— The 2009 H1N1 Influenza Vaccination Campaign
— In spring 2010, the Institute of Medicine’s Preparedness Forum organized three workshops to discuss and examine the vaccination campaign. The workshops were held in Raleigh, North Carolina (April 15); Austin, Texas (April 27); and Seattle, Washington (May 11). They were organized by a planning committee that included representatives from relevant federal agencies and state and local public health authorities and associations. The workshops were designed to facilitate a series of conversations focused on the following objectives: Examine innovative efforts used to distribute and administer vaccine and discuss how they may inform future efforts; Examine how jurisdictions and providers interpreted and applied the Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices (CDC/ACIP) recommendations for use of 2009 H1N1 vaccine; Highlight successful approaches used by jurisdictions to develop and use innovative partnerships with traditional and non-traditional partners, such as community groups and the private sector; and Discuss strategies used to collect, monitor, evaluate, and use data during the 2009 H1N1 vaccination campaigns.

(*5e05c158*):: +public!
Second International Summit on Human Genome Editing: Continuing the Global Discussion Jan 2019
Within a month after the summit concluded, nearly 100,000 additional individuals viewed the archived video of the webcast.
— Second International Summit on Human Genome Editing: Continuing the Global Discussion
— On November 27-29, 2018, the U.S. National Academy of Sciences and U.S. National Academy of Medicine, the Royal Society of the United Kingdom, and the Academy of Sciences of Hong Kong convened the Second International Summit on Human Genome Editing at the University of Hong Kong. The summit brought together more than 500 researchers, ethicists, policymakers, representatives from scientific and medical academies, patient group representatives, and others from around the world. Over the two-and-a-half-day event, topics including the potential benefits and risks of human genome editing, ethical and cultural perspectives, regulatory and policy considerations, and public outreach and engagement efforts were explored. This publication summarizes the presentations and discussions from the event.

(*5e05c158*):: +public! Bookmark this*

— CoronaCentral
— A portal to the entire coronavirus research literature

(*5e05c158*):: +public! Priorities for the National Vaccine Plan. (2010)
— Initial Guidance for an Update of the National Vaccine Plan: A Letter Report to the National Vaccine Program Office
— NOTICE: The project that is the subject of this report was approved by the Governing Board of the National Research Council, whose members are drawn from the councils of the National Academy of Sciences, the National Academy of Engineering, and the Institute of Medicine. The members of the committee responsible for the report were chosen for their special competences and with regard for appropriate balance.

(*5e05c158*):: Google financed it. Then Censored it.

Back to top